{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:44:49Z","timestamp":1791189889715,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.neulet.2010.02.062","type":"journal-article","created":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T04:50:06Z","timestamp":1267505406000},"page":"9-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients"],"prefix":"10.1016","volume":"474","author":[{"given":"Ewa","family":"Papu\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelmasiak","family":"Zbigniew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grieb","family":"Pawe\u0142","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rejdak","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2010.02.062_bib1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/ana.10551","article-title":"Early Treatment of Multiple Sclerosis Study Group. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta-1a","volume":"53","author":"Barkhof","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2010.02.062_bib2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s004150070148","article-title":"MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue","volume":"247","author":"Colombo","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.neulet.2010.02.062_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1006\/nimg.2001.1011","article-title":"Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis","volume":"15","author":"Filippi","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.neulet.2010.02.062_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1191\/1352458502ms839oa","article-title":"Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters","volume":"8","author":"Flachenecker","year":"2002","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neulet.2010.02.062_bib5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.sleep.2005.05.001","article-title":"Daytime sleepiness is not increased in mild to moderate multiple sclerosis: a pupillographic study","volume":"6","author":"Frauscher","year":"2005","journal-title":"Sleep Med."},{"key":"10.1016\/j.neulet.2010.02.062_bib6","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1073\/pnas.96.19.10911","article-title":"Orexin A activates locus coeruleus cell firing and increases arousal in the rat","volume":"96","author":"Benham","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2010.02.062_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1056\/NEJM198301273080401","article-title":"Intensive immunosupression in progressive multiple sclerosis. A randomized, three-arm study of high dose intravenous cyclophosphamide, plasma exchange, and ACTH","volume":"308","author":"Hauser","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neulet.2010.02.062_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/jnnp.2005.065805","article-title":"Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?","volume":"77","author":"Heesen","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2010.02.062_bib9","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.neulet.2010.02.062_bib10","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1196\/annals.1417.026","article-title":"Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems","volume":"1129","author":"Jones","year":"2008","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neulet.2010.02.062_bib11","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2169\/internalmedicine.42.743","article-title":"Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions","volume":"42","author":"Kato","year":"2003","journal-title":"Intern. Med."},{"key":"10.1016\/j.neulet.2010.02.062_bib12","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/1352458508088939","article-title":"Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis","volume":"14","author":"Knudsen","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neulet.2010.02.062_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/135245850000600213","article-title":"Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern","volume":"6","author":"Kroencke","year":"2000","journal-title":"Mult. Scler."},{"key":"10.1016\/j.neulet.2010.02.062_bib14","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","article-title":"The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus","volume":"46","author":"Krupp","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2010.02.062_bib15","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00023210-200317040-00002","article-title":"Fatigue in multiple sclerosis, definition, pathophysiology and treatment","volume":"17","author":"Krupp","year":"2003","journal-title":"CNS drugs"},{"key":"10.1016\/j.neulet.2010.02.062_bib16","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/1531-8249(200005)47:5<606::AID-ANA8>3.0.CO;2-L","article-title":"The motor cortex shows adaptive functional changes to brain injury from multiple sclerosis","volume":"47","author":"Lee","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2010.02.062_bib17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1006\/nimg.2001.0759","article-title":"Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement\u2014EEG evidence","volume":"13","author":"Leocani","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.neulet.2010.02.062_bib18","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2010.02.062_bib19","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/S1389-9457(04)90001-9","article-title":"Sleep, sleep disorders and hypocretin (orexin)","volume":"1","author":"Mignot","year":"2004","journal-title":"Sleep Med. suppl."},{"key":"10.1016\/j.neulet.2010.02.062_bib20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0306-4522(03)00461-5","article-title":"Stimulant doses of caffeine induce c-FOS activation in orexin\/hypocretin-containing neurons in rat","volume":"121","author":"Murphy","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2010.02.062_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2005.03.004","article-title":"Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin\/orexin system","volume":"9","author":"Nishino","year":"2005","journal-title":"Sleep Med. Rev."},{"key":"10.1016\/j.neulet.2010.02.062_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2010.02.062_bib23","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/brain\/123.11.2314","article-title":"Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis","volume":"123","author":"Reddy","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2010.02.062_bib24","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1212\/WNL.57.12.2253","article-title":"CSF hypocretin\/orexin levels in narcolepsy and other neurological conditions","volume":"57","author":"Ripley","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2010.02.062_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/ana.10120","article-title":"Adaptive functional changes in the cerebral cortex of patients with nondisabling multiple sclerosis correlate with the extent of brain structural damage","volume":"51","author":"Rocca","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neulet.2010.02.062_bib26","doi-asserted-by":"crossref","first-page":"8620","DOI":"10.1523\/JNEUROSCI.20-22-08620.2000","article-title":"Hypothalamic arousal regions are activated during modafinil-induced wakefulness","volume":"20","author":"Scammell","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2010.02.062_bib27","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.neuro.25.112701.142826","article-title":"The role of hypocretins (orexins) in sleep regulation and narcolepsy","volume":"25","author":"Taheri","year":"2002","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2010.02.062_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archneur.61.2.201","article-title":"The relationship between diffuse axonal damage and fatigue in multiple sclerosis","volume":"61","author":"Tartaglia","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2010.02.062_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2010.02.062_bib30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev.neuro.24.1.429","article-title":"To eat or to sleep? Orexin in the regulation of feeding and wakefulness","volume":"24","author":"Willie","year":"2001","journal-title":"Annu. Rev. Neurosci."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394010002466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394010002466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T20:10:26Z","timestamp":1759608626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394010002466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0304394010002466"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2010.02.062","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF hypocretin-1 concentrations correlate with the level of fatigue in multiple sclerosis patients","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2010.02.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}